ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator

SINGAPORE, Mar 31, 2023 – (ACN Newswire) – ACROMETA Group Limited, a recognized professional engineering company in the field of regulated environments serving primarily the health care, biotechnology, pharmaceutical, research study and academic community sectors, has actually participated in a Sales and Purchase Agreement (“the Agreement”) for an extra 40% of the impressive shares of Life Sciences Incubator Pte Ltd (“LSI”) for an overall factor to consider of S$ 1.6 million payable in tranches, based upon the realisation of concurred turning points in its instant growth strategy. Upon conclusion of the purchase, the Group will manage 70% of LSI, up from the present 30%.

The Agreement updates and follows from the Letter of Intent (“LOI”) revealed to SGXNet on 20 February 2023 for the proposed acquisition of an extra 40% stake in LSI.

A website check out to Brisbane and the due diligence performed by ACROMETA Management have actually shortlisted the area of the proposed co-working lab in Australia as it discovered it ideal.

Mr Levin Lee Keng Weng, ACROMETA Chairman, stated, “Brisbane is a growing center for the Life Sciences sector in Australia. According to Global Australia[1]a government-industry advancement firm, Queensland is house to more than 250 life sciences organisations, 85 core biotech business, and more than 100 biotech-related research study organisations.

An entire community has actually emerged with clusters of vibrant and ingenious SMEs and start-ups either performing their R&D or supporting the multinationals and research study centres concentrating on biotechnology, pharmaceuticals, medical gadgets and professional health care such as gerontology and neurology.”

Mr Lee included, “The need for co-working lab area is strong. The efficiency turning points for the payment in tranches accepted by the Vendor show that both the Purchaser and the Vendor believe in the co-working lab company in Australia and Singapore.

The proposed extra co-working lab area in Singapore is to cater for anticipated development in need. In addition, as Singapore changes its economy towards high-value sectors, a growing number of SMEs and start-ups performing their R & & D will need co-working lab area.”

This Media Release is to be checked out in combination with the statement on SGXNet on 31 March 2023.


About ACROMETA Group Limited (SGX Stock Code:43 F)

ACROMETA (Previously called ACROMEC Limited) is a recognized professional engineering providers with more than 25 years of experience in the field of regulated environments.

The Group has, for many years, gotten competence in the style and building and construction of centers needing regulated environments such as labs, medical and sterilized centers and cleanrooms.

ACROMETA’s company is divided into 3 primary service sectors: (i) Engineering, procurement, and building services, specialising in architectural, and mechanical, electrical, and procedure works within regulated environments; (ii) Maintenance and repair work services of centers and devices of regulated environments and their supporting facilities. (iii) Co-Working Laboratory company; presently runs a 6,500 sq feet co-working lab area at The German Centre in Singapore serving SMEs and start-ups.

The Group generally serves the health care, biotechnology, pharmaceutical, research study and academic community, and electronic devices sectors. ACROMETA’s clients consist of medical facilities and medical centres, federal government companies, research study and advancement business or companies, research study and advancement systems of international corporations, tertiary universities, pharmaceutical business, semiconductor production business, and international engineering business.

The Company has actually been noted on the Catalist board of the Singapore Exchange considering that 2016. To learn more, please see

Media and Analysts Contact:

ACROMETA Group Limited
Mr. Jerry Tan
Chief Financial Officer
Tel: +65 6415 0574

Waterbrooks Consultants Pte Ltd
Mr. Wayne Koo
Tel: +65 6958 8008/ +65 9338 8166

This media release has actually been examined by the Company’s sponsor, Evolve Capital Advisory Private Limited (the “Sponsor”). It has actually not been taken a look at or authorized by the Singapore Exchange Securities Trading Limited (the “Exchange”), and the Exchange presumes no duty for the contents of this file, consisting of the accuracy of any of the declarations or viewpoints made or reports consisted of in this file.

The contact individual for the Sponsor is Mr. Jerry Chua, 138 Robinson Road, # 13-02 Oxley Tower, Singapore 068906,

Subject: Press release summary

Source: AcroMeta Group Limited

Sectors: Daily Finance, Daily News, BioTech, Healthcare & & Pharm

From the Asia Corporate News Network

Copyright © 2023 ACN Newswire. All rights booked. A department of Asia Corporate News Network.

Leave a Reply

Your email address will not be published. Required fields are marked *